Axogen Inc vs SPDR Gold Trust — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while SPDR Gold Trust trades at $370.51. The key difference: Axogen Inc is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals.
| AXGN | GLD | |
|---|---|---|
Market Cap | $2.06B | — |
Sector | Technology | — |
52-Week High | $46.19 | $495.90 |
52-Week Low | $11.28 | $300.96 |
Enterprise Value | $1.98B | — |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
GLD trades at $367.13, down 2.59% amid a bearish technical setup with 19 sell signals versus 2 buys. Support lies at $365 and $363, while resistance is at $370 and $374. Recent news highlights gold's volatility from inflation data and Fed policy shifts, with prices testing key levels after softer CPI provided temporary relief.
The outlook remains cautious as rising yields and dollar strength pressure gold. Near-term direction hinges on Fed rate expectations and geopolitical tensions. Risks include prolonged high rates eroding gold's appeal, while potential inflation spikes or market instability could renew safe-haven demand.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →